Tag: AXS-05
-
Axsome Stock Up Big on Encouraging Alzheimer’s News
Shares of Axsome Therapeutics (AXSM) were up about 32% on a volume spike to 10.65 million shares, as compared to daily average volume of 1.28 million shares. All after the company’s “AXS-05, a novel, oral, investigational NMDA receptor antagonist with multimodal activity, met the primary and key secondary endpoints in the ACCORD (Assessing Clinical Outcomes…